TY - JOUR

T1 - Incidence rate and factors associated with fractures among Medicare beneficiaries with ankylosing spondylitis in the United States

AU - Stovall, Rachael

AU - Kersey, Emma

AU - Li, Jing

AU - Baker, Rahaf

AU - Anastasiou, Christine

AU - Palmowski, Andriko

AU - Schmajuk, Gabriela

AU - Gensler, Lianne

AU - Yazdany, Jinoos

N1 - This article is protected by copyright. All rights reserved.

PY - 2024

Y1 - 2024

N2 - OBJECTIVE: We evaluated the incidence rate and factors associated with fractures among adults with ankylosing spondylitis (AS).METHODS: We performed a retrospective cohort study with data from the Rheumatology Informatics System for Effectiveness (RISE) registry linked to Medicare claims from 2016-2018. Patients were required to have two AS ICD codes, ≥30 days apart, and a subsequent Medicare claim. Then, one year of baseline characteristics were included, after which patients were observed for fractures. First, we calculated the incidence rate of fractures. Second, we constructed logistic regression models to identify factors associated with fracture, including age, sex, race/ethnicity, body mass index, Medicare/Medicaid dual-eligibility, area deprivation index, Charlson comorbidity index, smoking status, osteoporosis, historical fracture, and use of osteoporosis treatment, glucocorticoids, and opioids.RESULTS: We identified 1,426 adults with prevalent AS. Mean (SD) age was 69.4 years (9.8), 44.3% were female, and 77.3% were non-Hispanic White. Fractures occurred in 197 adults with AS. The overall incidence rate of fractures was 76.7 (95% CI 66.4-88.6) per 1,000 person-years. Older age (OR 2.8, 95% CI 1.39-5.65), historical fracture (OR 5.24, 95% CI 3.44-7.99), and use of >30 mg morphine equivalent (OR 1.86, 95% CI 1.08-3.19) conferred increased odds of fracture.CONCLUSIONS: In this large sample of Medicare beneficiaries with AS, increasing age, historical fracture, and use of opioids had a higher odds of fracture. Men and women were equally likely to have a fracture. Because opioid use was associated with fracture in AS, this high-risk population should be considered for interventions to mitigate risk. This article is protected by copyright. All rights reserved.

AB - OBJECTIVE: We evaluated the incidence rate and factors associated with fractures among adults with ankylosing spondylitis (AS).METHODS: We performed a retrospective cohort study with data from the Rheumatology Informatics System for Effectiveness (RISE) registry linked to Medicare claims from 2016-2018. Patients were required to have two AS ICD codes, ≥30 days apart, and a subsequent Medicare claim. Then, one year of baseline characteristics were included, after which patients were observed for fractures. First, we calculated the incidence rate of fractures. Second, we constructed logistic regression models to identify factors associated with fracture, including age, sex, race/ethnicity, body mass index, Medicare/Medicaid dual-eligibility, area deprivation index, Charlson comorbidity index, smoking status, osteoporosis, historical fracture, and use of osteoporosis treatment, glucocorticoids, and opioids.RESULTS: We identified 1,426 adults with prevalent AS. Mean (SD) age was 69.4 years (9.8), 44.3% were female, and 77.3% were non-Hispanic White. Fractures occurred in 197 adults with AS. The overall incidence rate of fractures was 76.7 (95% CI 66.4-88.6) per 1,000 person-years. Older age (OR 2.8, 95% CI 1.39-5.65), historical fracture (OR 5.24, 95% CI 3.44-7.99), and use of >30 mg morphine equivalent (OR 1.86, 95% CI 1.08-3.19) conferred increased odds of fracture.CONCLUSIONS: In this large sample of Medicare beneficiaries with AS, increasing age, historical fracture, and use of opioids had a higher odds of fracture. Men and women were equally likely to have a fracture. Because opioid use was associated with fracture in AS, this high-risk population should be considered for interventions to mitigate risk. This article is protected by copyright. All rights reserved.

U2 - 10.1002/acr.25219

DO - 10.1002/acr.25219

M3 - Journal article

C2 - 37605840

VL - 76

SP - 265

EP - 273

JO - Arthritis Care & Research

JF - Arthritis Care & Research

SN - 2151-464X

IS - 2

ER -